Daslemia 70 mg Tablet
  1. Home
  2. Pharma Products
  3. Intas Pharmaceuticals Ltd
  4. Daslemia 70 mg Tablet

Daslemia 70 mg Tablet

Daslemia 70 mg Tablet contains dasatinib 70 mg and is an oral targeted anticancer medicine. It is used mainly for Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia. The tablet is a prescription medicine and should be taken under specialist medical supervision.

BUY NOW

Category

Dasatinib is a tyrosine kinase inhibitor that blocks abnormal BCR-ABL and other kinase proteins involved in the growth of certain leukemia cells. This targeted action helps reduce the multiplication of abnormal blood cells and control disease progression. Regular monitoring of blood counts and clinical parameters is important because treatment can cause myelosuppression, fluid retention, bleeding, and other adverse effects. The dose and treatment duration are determined by the treating oncologist according to the leukemia type and individual treatment response.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 70 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 60 tablets
Manufacturer / Marketer Intas Pharmaceuticals Ltd

Product Also Known As

Daslemia 70mg Tablet, Daslemia 70 mg Tablet, Dasatinib 70mg Tablet, Dasatinib 70 mg Tablet, Dasatinib Oral Tablet, Dasatinib 70mg Anticancer Tablet, Dasatinib Leukemia Tablet